Therapy in Patients with Chronic Myeloid Leukemia Outside of Clinical Trials: Results of the German CML-Registry (CML-VI)

被引：0

作者：

Kohlbrenner, Katharina ^{[1
]}

Galuschek, Norbert ^{[1
]}

Fabarius, Alice ^{[1
]}

Reiser, Marcel

Fenchel, Klaus ^{[2
]}

Esseling, Eva ^{[3
]}

Goehler, Thomas ^{[4
]}

Geer, Thomas ^{[5
]}

Depenbusch, Reinhard ^{[6
]}

Azeh, Ivo Talah ^{[7
]}

Engel, Erik ^{[8
]}

Hansen, Richard ^{[9
]}

Lindemann, Hans-Walter ^{[10
]}

Anhuf, Juergen ^{[11
]}

Jehner, Paul ^{[12
]}

Abu-Samra, Maisun ^{[13
]}

Ritter, Markus ^{[14
]}

Gattermann, Norbert ^{[15
]}

Pelz, Henning ^{[16
]}

Fuxius, Stefan ^{[17
]}

Oswald, Burkhard ^{[18
]}

Baerlocher, Gabriela M. ^{[19
,20
]}

Brummendorf, Tim H. H. ^{[21
]}

Heim, Dominik ^{[22
]}

le Coutre, Philipp ^{[23
]}

Burchert, Andreas ^{[24
]}

Niederwieser, Dietger ^{[25
]}

Tesch, Hans ^{[26
]}

Hofmann, Wolf-Karsten ^{[1
]}

Hochhaus, Andreas ^{[27
]}

Hehlmann, Ruediger ^{[28
]}

Saussele, Susanne ^{[1
]}

机构：

[1] Heidelberg Univ, Med Fak Mannheim, Med Klin 3, Mannheim, Germany

[2] Onkol Praxisklin Hamatol Onkol & Gerinnungsstorun, Saalfeld, Germany

[3] Univ Klinikum Munster, Med Klin A, Munster, Germany

[4] Onkozentrum Dresden, Dresden, Germany

[5] Diakonie Klinikum, Innere Med 3, Schwabisch Hall, Germany

[6] Onkol Gemeinschaftspraxis Dres Depenbusch, Schutt and Sonnenberg, Gutersloh, Germany

[7] Onkol Gemeinschaftspraxis & Tagesklin Dres Med C, Gelsenkirchen, Germany

[8] Hamatol Onkol Praxis Altona HOPA, Hamburg, Germany

[9] Onkol Gemeinschaftspraxis Dres Hansen & Reeb, Kaiserslautern, Germany

[10] Katholisches Krankenhaus, Hamatol & Onkol, Hagen, Germany

[11] Onkol Duisburg Nord, Duisburg, Germany

[12] Onkol Praxis Moers, Moers, Germany

[13] Univ Klinikum Giessen & Marburg, Med Klin & Poliklin Hamatol 4, Giessen, Germany

[14] MVZ Sindelfingen, Onkol Praxis, Sindelfingen, Germany

[15] Univ Klinikum Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany

[16] Ambulantes Therapiezentrum Hamatol & Onkol, Offenburg, Germany

[17] Onkol Schwerpunktpraxis Heidelberg, Heidelberg, Germany

[18] Onkol Schwerpunktpraxis Worms, Worms, Germany

[19] Univ Klin Hamatol, Inselspital Bern, Bern, Switzerland

[20] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland

[21] Univ Klinikum RWTH Aachen, Med Klin 4, Aachen, Germany

[22] Univ Spital Basel, Klin Hamatol, Basel, Switzerland

[23] Charite Univ Med Berlin, Campus Virchow Med Klin S Hamatol & Onkol, Berlin, Germany

[24] Univ Klinikum Giessen & Marburg, Hamatol Onkol & Immunol, Marburg, Germany

[25] Univ Klinikum Leipzig, Abt Hamatol & Internist Onkol, Leipzig, Germany

[26] Ctr Hamatol & Onkol Bethanien, Frankfurt, Germany

[27] Univ Klinikum Jena, Abt Hamatol & Internist Onkol, Klin Innere Med 2, Jena, Germany

[28] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-159412

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
Rea, Delphine
Mauro, Michael J.
Cortes, Jorge E.
Jiang, Qian
Pagnano, Katia B.
Ongondi, Matilda
Kok, Chung Hoow
Evans, Nicola
Hughes, Timothy P.
BLOOD, 2020, 136
[32] Results of a Phase II Trial of Dasatinib As Frontline Therapy for Chronic Myeloid Leukemia (CML) In Chronic Phase (CP)
Pemmaraju, Naveen
Kantarjian, Hagop M.
Luthra, Rajyalakshmi
O'Brien, Susan
Jabbour, Elias
Quintas-Cardama, Alfonso
Borthakur, Gautam
Ravandi, Farhad
Verstovsek, Srdan
Burton, Elizabeth
Walker, Brenda
Cortes, Jorge E.
BLOOD, 2011, 118 (21) : 740 - 741
[33] The Experience of the International Registry for Chronic Myeloid Leukemia (CML) in Children and Adolescents (I-CML-Ped Study): Pronostic Consideration
Millot, Frederic
Guilhot, Joelle
Suttorp, Meinolf
Sedlacek, Petr
de Bont, Eveline S. J. M.
Li, Chi Kong
Kalwak, Krzysztof
Lausen, Birgitte
Srdjana, Culic
Dresse, Marie-Francoise
Biondi, Andrea
Baruchel, Andre
BLOOD, 2014, 124 (21)
[34] SIGNIFICANCE OF ANEMIA IN PATIENTS WITH CML AT DIAGNOSIS AND DURING THE TREATMENT WITH IMATINIB OUTSIDE THE CLINICAL TRIALS: CAMELIA REGISTRY EXPERIENCE
Faber, E.
Muzik, J.
Janousova, E.
Dufkova, T.
Jindra, P.
Cmunt, E.
Sninska, Z.
Demitrovicova, L.
Mikuskova, E.
Chudej, J.
Markuljak, I.
Palasthy, S.
Stecova, N.
Tothova, E.
Dusek, L.
Indrak, K.
HAEMATOLOGICA, 2015, 100 : 445 - 445
[35] INVESTIGATIONS ON KARYOTYPE EVOLUTION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML)
HAAS, OA
SCHWARZMEIER, JD
NACHEVA, E
FISCHER, P
PAIETTA, E
BLUT, 1984, 48 (01): : 33 - 43
[36] ADENOPATHIES IN CHRONIC MYELOID-LEUKEMIA (CML) - OBSERVATIONS ON 161 PATIENTS
PAOLINO, W
INFELISE, V
DEGANI, G
FALDA, M
PAOLINO, F
FIORIO, C
MARMONT, F
CODA, R
MINERVA MEDICA, 1980, 71 (30) : 2115 - 2123
[37] WT1 ANALYSIS IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
Coluzzi, S.
Introcaso, T.
Iallorenzi, P.
Villani, O.
Bianchino, G.
Pascale, S. P.
Nuccorini, R.
Attolico, I.
Vertone, D.
Filardi, N.
Matturro, A.
Amendola, A.
Cimminiello, M.
Pietrantuono, G.
Grieco, V.
Pizzuti, M.
HAEMATOLOGICA, 2016, 101 : S101 - S101
[38] IMATINIB MESYLATE INDUCED HEPATOTOXICITY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML)
Milosevic, V.
Bogdanovic, A.
Djordjevic, V.
Fekete, M. Dencic
Mihaljevic, B.
Gotic, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 545 - 546
[39] Psychosocial profile and morbidity in Indian patients with Chronic Myeloid Leukemia (CML)
Malhotra, P.
Gupta, N.
Dogra, S.
Mahi, S. K.
Varma, S.
Kulhara, P.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[40] IMATINIB MESYLATE IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS
Ionita, H.
Ionita, I.
Cheveresan, M.
Iordache, M.
Cheveresan, L.
Ionita, M.
Borzak, G.
Ionita, C. O.
Pascalau, A.
Calamar, D.
Oros, D.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 548 - 548

← 1 2 3 4 5 →